106 related articles for article (PubMed ID: 24788309)
1. Urinary phytate (Myo-inositol hexaphosphate) in healthy school children and risk of nephrolithiasis.
Grases F; Saez-Torres C; Rodriguez A; Costa-Bauza A; Rodrigo D; Frontera G; Berga F; Fakier S
J Ren Nutr; 2014 Jul; 24(4):219-23. PubMed ID: 24788309
[TBL] [Abstract][Full Text] [Related]
2. Protective Effect of Myo-Inositol Hexaphosphate (Phytate) on Abdominal Aortic Calcification in Patients With Chronic Kidney Disease.
Sanchis P; Buades JM; Berga F; Gelabert MM; Molina M; Íñigo MV; García S; Gonzalez J; Bernabeu MR; Costa-Bauzá A; Grases F
J Ren Nutr; 2016 Jul; 26(4):226-36. PubMed ID: 26975775
[TBL] [Abstract][Full Text] [Related]
3. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
4. Effects of Mediterranean diets with low and high proportions of phytate-rich foods on the urinary phytate excretion.
Prieto RM; Fiol M; Perello J; Estruch R; Ros E; Sanchis P; Grases F
Eur J Nutr; 2010 Sep; 49(6):321-6. PubMed ID: 20108098
[TBL] [Abstract][Full Text] [Related]
5. Urinary lithogen risk test: usefulness in the evaluation of renal lithiasis treatment using crystallization inhibitors (citrate and phytate).
Conte A; Pizá P; García-Raja A
Arch Esp Urol; 1999; 52(1):94-9. PubMed ID: 10101897
[TBL] [Abstract][Full Text] [Related]
6. Exploring the Potential Relationship Between Phytate Ingestion, Urinary Phytate Excretion, and Renal Stone Risk in a Unique Human Model: No Hard Evidence in Support of Phytate as a Stone Inhibitor.
Fakier S; Rodgers A
J Ren Nutr; 2020 Sep; 30(5):396-403. PubMed ID: 31928801
[TBL] [Abstract][Full Text] [Related]
7. Phytate (myo-inositol hexaphosphate) and risk factors for osteoporosis.
López-González AA; Grases F; Roca P; Mari B; Vicente-Herrero MT; Costa-Bauzá A
J Med Food; 2008 Dec; 11(4):747-52. PubMed ID: 19053869
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for urinary stones in healthy schoolchildren with and without a family history of nephrolithiasis.
Sáez-Torres C; Grases F; Rodrigo D; García-Raja AM; Gómez C; Frontera G
Pediatr Nephrol; 2013 Apr; 28(4):639-45. PubMed ID: 23212561
[TBL] [Abstract][Full Text] [Related]
9. Urinary lithogen risk test: usefulness in the evaluation of renal lithiasis treatment using crystallization inhibitors (citrate and phytate).
Conte A; Pizá P; García-Raja A; Grases F; Costa-Bauzá A; Prieto RM
Arch Esp Urol; 1999 Apr; 52(3):305-10. PubMed ID: 10371752
[TBL] [Abstract][Full Text] [Related]
10. [Simple obesity in children. A study on the role of nutritional factors].
Weker H
Med Wieku Rozwoj; 2006; 10(1):3-191. PubMed ID: 16733288
[TBL] [Abstract][Full Text] [Related]
11. Effects of inositol hexaphosphate (phytate) on calcium binding, calcium oxalate crystallization and in vitro stone growth.
Saw NK; Chow K; Rao PN; Kavanagh JP
J Urol; 2007 Jun; 177(6):2366-70. PubMed ID: 17509360
[TBL] [Abstract][Full Text] [Related]
12. Key Aspects of Myo-Inositol Hexaphosphate (Phytate) and Pathological Calcifications.
Grases F; Costa-Bauza A
Molecules; 2019 Dec; 24(24):. PubMed ID: 31817119
[TBL] [Abstract][Full Text] [Related]
13. Importance of citrate and the calcium : citrate ratio in patients with calcium renal lithiasis and severe lithogenesis.
Arrabal-Polo MA; Arrabal-Martin M; Arias-Santiago S; Garrido-Gomez J; Poyatos-Andujar A; Zuluaga-Gomez A
BJU Int; 2013 Apr; 111(4):622-7. PubMed ID: 22757744
[TBL] [Abstract][Full Text] [Related]
14. [Citrate and renal stones].
del Valle EE; Spivacow FR; Negri AL
Medicina (B Aires); 2013; 73(4):363-8. PubMed ID: 23924538
[TBL] [Abstract][Full Text] [Related]
15. Relationship between Urinary Level of Phytate and Valvular Calcification in an Elderly Population: A Cross-Sectional Study.
Fernández-Palomeque C; Grau A; Perelló J; Sanchis P; Isern B; Prieto RM; Costa-Bauzá A; Caldés OJ; Bonnin O; Garcia-Raja A; Bethencourt A; Grases F
PLoS One; 2015; 10(8):e0136560. PubMed ID: 26322979
[TBL] [Abstract][Full Text] [Related]
16. [Hypocitraturia in children with urolithiasis].
Kamińska A; Jung A; Piechota W; Kałuza D
Pol Merkur Lekarski; 2000 Apr; 8(46):181-2. PubMed ID: 10897602
[TBL] [Abstract][Full Text] [Related]
17. Low zinc, iron, and calcium intakes of Northeast Thai school children consuming glutinous rice-based diets are not exacerbated by high phytate.
Krittaphol W; Bailey KB; Pongcharoen T; Winichagoon P; Gibson RS
Int J Food Sci Nutr; 2006; 57(7-8):520-8. PubMed ID: 17162330
[TBL] [Abstract][Full Text] [Related]
18. Factors Associated With the Lower Prevalence of Nephrolithiasis in Children Compared With Adults.
Grases F; Rodriguez A; Costa-Bauza A; Saez-Torres C; Rodrigo D; Gómez C; Mir-Perello C; Frontera G
Urology; 2015 Sep; 86(3):587-92. PubMed ID: 26144339
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Mixtures of Magnesium, Citrate and Phytate as Calcium Oxalate Crystallization Inhibitors in Urine.
Grases F; Rodriguez A; Costa-Bauza A
J Urol; 2015 Sep; 194(3):812-9. PubMed ID: 25818031
[TBL] [Abstract][Full Text] [Related]
20. Relationship between body mass index and quantitative 24-hour urine chemistries in patients with nephrolithiasis.
Eisner BH; Eisenberg ML; Stoller ML
Urology; 2010 Jun; 75(6):1289-93. PubMed ID: 20018350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
